Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-life Evaluation of an Applicator, as a New Mode of Administration of Daivobet® Gel, on Adherence to Treatment and SAtisfaction of Patients With PSOriasis

NCT02856542 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02856542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02856542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-life Evaluation of an Applicator, as a New Mode of Administration of Daivobet® Gel, on Adherence to Treatment and SAtisfaction of Patients With PSOriasis
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
May 23, 2016
Completion date
June 30, 2017
Enrollment
1,560 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis